Back to homepage

Tag "Pfizer"

Pfizer applies to US FDA for two-dose vaccine for kids under 5

Pfizer applies to US FDA for two-dose vaccine for kids under 5

🕔18:12, 2.Feb 2022

Washington, Feb 2 (IANS) US drugmaker Pfizer has applied to the Food and Drug Administration (FDA) to authorise two doses of their Covid vaccine for children younger than five years, the media reported. Although a clinical trial among children in the

Read Full Article
US CDC authorizes Covid-19 vaccine boosters for all adults

US CDC authorizes Covid-19 vaccine boosters for all adults

🕔12:37, 20.Nov 2021

New York, Nov 20 (IANS) The United States Centers for Disease Control and Prevention (CDC) endorsed booster doses of Pfizer/BioNTech’s and Moderna’s Covid-19 vaccines for all US adults. “CDC continues to encourage the 47 million adults who are not yet vaccinated

Read Full Article
Pfizer to soon submit data on Covid vax for kids aged 5-11  (18:06)

Pfizer to soon submit data on Covid vax for kids aged 5-11 (18:06)

🕔18:11, 27.Sep 2021

Washington, Sep 27 (IANS) Pfizer is soon expected to submit data to the US Food and Drug Administration (FDA) regarding safety of its mRNA Covid vaccine for children ages 5 to 11, media reports said. “It’s a question of days, not

Read Full Article
UK approves Pfizer, AstraZeneca as booster jabs for Covid

UK approves Pfizer, AstraZeneca as booster jabs for Covid

🕔17:24, 10.Sep 2021

London, Sep 10  The UK’s health regulator has approved Pfizer and AstraZeneca vaccines for booster doses against Covid-19, even as the country’s decision on the third dose remains pending. “We know that a person’s immunity may decline over time after

Read Full Article
Pfizer to explore pneumococcal jab with 3rd booster of Covid vax

Pfizer to explore pneumococcal jab with 3rd booster of Covid vax

🕔20:32, 24.May 2021

New York, May 24  Pfizer on Monday announced a study to explore coadministration of its pneumococcal vaccine along with a third dose of the Pfizer-BioNTech Covid-19 vaccine in older adults. Pfizer, in a statement, announced that “the first enrolled subjects

Read Full Article
Pfizer in talks with India on vax approval, says CEO

Pfizer in talks with India on vax approval, says CEO

🕔07:04, 5.May 2021

New York, May 5  Pfizer is discussing expedited approval of its Covid-19 vaccine with the Indian government, company CEO Alber Bourla said while announcing a donation of medicines worth $70 million to fight the resurgent pandemic. “We are currently discussing

Read Full Article
Single dose of Pfizer, AstraZeneca can cut Covid transmission by 50%

Single dose of Pfizer, AstraZeneca can cut Covid transmission by 50%

🕔18:04, 28.Apr 2021

London, April 28  A single dose of a Pfizer or AstraZeneca vaccine against coronavirus disease can reduce transmission by up to 50 per cent, finds a study. The study led by UK’s Public Health England (PHE) showed that people who

Read Full Article
Pfizer offers Covid jabs at ‘not-for-profit’ price in India

Pfizer offers Covid jabs at ‘not-for-profit’ price in India

🕔18:12, 22.Apr 2021

New Delhi, April 22 US pharma major Pfizer on Thursday offered to supply the Pfizer-BioNTech vaccine at a “not-for-profit” price, media reports have cited. The company had earlier said that it will supply the messenger RNA (mRNA) vaccine only through government

Read Full Article
Russia’s Sputnik V to cost lower than Pfizer, Moderna’s Covid vax

Russia’s Sputnik V to cost lower than Pfizer, Moderna’s Covid vax

🕔15:08, 23.Nov 2020

Moscow, Nov 23  Russia’s Sputnik V vaccine against Covid-19 will cost governments much lower than that of Pfizer’s and Moderna’s, the official Twitter handle of the world’s first registered vaccine against the pandemic said on Sunday. “Translating pharma lingo: the

Read Full Article
Pfizer’s record breaking 9 month sprint to Covid-19 vaccine: A timeline

Pfizer’s record breaking 9 month sprint to Covid-19 vaccine: A timeline

🕔20:10, 20.Nov 2020

New York, Nov 20  Pfizer announced Friday it is seeking emergency approval from US regulators for its Covid-19 vaccine, which has shown 95 percent efficacy in a totality of two data sets released in the last 10 days. The chief

Read Full Article
Pfizer to seek emergency approval for vaccine

Pfizer to seek emergency approval for vaccine

🕔19:34, 20.Nov 2020

New York, Nov 20  Pfizer on Friday announced that it is moving ahead with its request of asking the US regulators to allow emergency use of its Covid-19 vaccine, which has shown 95 per cent efficacy in a totality of

Read Full Article
Pfizer 2-dose vaccine 95% effective, no serious side effects

Pfizer 2-dose vaccine 95% effective, no serious side effects

🕔19:46, 18.Nov 2020

New York, Nov 18  Pfizer and its German partner BioNTech released a second batch of interim results on Wednesday, saying their two-dose coronavirus vaccine candidate is 95 per cent effective and also protects the most vulnerable people in older age

Read Full Article
Pfizer, BioNTech pick US hospital as trial site for Covid vaccine

Pfizer, BioNTech pick US hospital as trial site for Covid vaccine

🕔17:12, 26.Aug 2020

New York, Aug 26  University Hospitals (UH) in the US has been selected as the clinical site to test for the Phase 2/3 of a possible Covid-19 vaccine — BNT162b2 — sponsored by the US-based pharmaceutical major Pfizer and German

Read Full Article
US hands Pfizer, BioNTech $1.95b order for 100m Covid vaccines

US hands Pfizer, BioNTech $1.95b order for 100m Covid vaccines

🕔07:38, 23.Jul 2020

New York, July 23  The US government has agreed to pay $1.95 billion for 100 million doses of a potential Covid-19 vaccine jointly developed by Pfizer and BioNTech, the two companies said on Wednesday. The doses of the vaccine, BNT162,

Read Full Article